Quarterly report pursuant to Section 13 or 15(d)

Schedule of Summarizes Information About Stock Options (Details) (Parenthetical)

v3.22.2.2
Schedule of Summarizes Information About Stock Options (Details) (Parenthetical) - 2018 Equity Plan [Member] - shares
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Stock options, Granted [1] 2,107,500  
Lucid Diagnostics Inc [Member]    
Stock options, Granted 423,300 423,300
Parent Company [Member]    
Stock options, Granted 500,854 500,854
[1] Stock options granted under the Lucid Diagnostics Inc. 2018 Equity Plan and those granted outside such plan generally vest ratably over twelve quarters, with the vesting commencing with the grant date quarter, and have a ten-year contractual term from date-of-grant.